National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 55374 [2018-24102]
Download as PDF
<![CDATA[
55374
Federal Register / Vol. 83, No. 214 / Monday, November 5, 2018 / Notices
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 31, 2018.
Leslie Kux,
Associate Commissioner for Policy.
Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–24177 Filed 11–2–18; 8:45 am]
BILLING CODE 4164–01–P
[FR Doc. 2018–24102 Filed 11–2–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel ‘‘Vaccine Adjuvant
Discovery Program’’.
Date: November 28–29, 2018.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Geetanjali Bansal, Ph.D.,
Scientific Reviewer Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G49, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9834,
Bethesda, MD 20892–9834, (240) 669–5073,
geetanjali.bansal@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Clinical Trial
Implementation Cooperative Agreement
(U01).
Date: November 29, 2018.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Kumud K. Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852, 301–761–7830, kumud.singh@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
VerDate Sep<11>2014
18:38 Nov 02, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; NIH Office of Intramural
Training & Education—Application,
Registration, and Alumni Systems,
Office of the Director
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health Office of
Intramural Training & Education (OITE)
will publish periodic summaries of
propose projects to be submitted to the
Office of Management and Budget
(OMB) for review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Patricia Wagner, Program
Analyst, Office of Intramural Training &
Education (OITE), Office of Intramural
Research (OIR), Office of the Director
(OD), National Institutes of Health
(NIH); 2 Center Drive: Building 2/Room
2E06; Bethesda, Maryland 20892 or call
non-toll-free number 240–476–3619 or
Email your request, including your
address to: wagnerpa@od.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
FOR FURTHER INFORMATION CONTACT:
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: NIH Office
of Intramural Training & Education—
Application, Registration, and Alumni
Systems, 0925–0299, 06/30/2019,
REVISION, Office of Intramural
Training & Education (OITE), Office of
Intramural Research (OIR), Office of the
Director (OD), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The Office of Intramural
Training & Education (OITE)
administers a variety of programs and
initiatives to recruit pre-college through
pre-doctoral educational level
individuals into the National Institutes
of Health Intramural Research Program
(NIH–IRP) to facilitate their
development into future biomedical
scientists. The proposed information
collection is necessary in order to
determine the eligibility and quality of
potential awardees for traineeships in
these programs. The applications for
admission consideration solicit
information including: Personal
information, ability to meet eligibility
criteria, contact information, universityassigned student identification number,
training program selection, scientific
discipline interests, educational history,
standardized examination scores,
reference information, resume
components, employment history,
employment interests, dissertation
research details, letters of
recommendation, financial aid history,
sensitive data, and travel information, as
well as feedback questions about
interviews and application submission
experiences. Sensitive data collected on
the applicants: Race, gender, ethnicity,
relatives at NIH, and recruitment
method, are made available only to
OITE staff members or in aggregate form
to select NIH offices and are not used by
the admission committees for admission
consideration. In addition, information
to monitor trainee placement after
departure from NIH is periodically
collected.
OMB approval is requested for 3
years. There are no costs to respondents
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 83, Number 214 (Monday, November 5, 2018)]
[Notices]
[Page 55374]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24102]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel ``Vaccine Adjuvant Discovery
Program''.
Date: November 28-29, 2018.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Geetanjali Bansal, Ph.D., Scientific Reviewer
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G49, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5073,
[email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel NIAID Clinical Trial Implementation
Cooperative Agreement (U01).
Date: November 29, 2018.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Kumud K. Singh, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers
Lane, MSC-9823, Rockville, MD 20852, 301-761-7830,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24102 Filed 11-2-18; 8:45 am]
BILLING CODE 4140-01-P
